Page 2 - Corona Remedies

JN.1 detected in Kerala: All you need to know about the Covid variant

The JN.1 sub-variant of Covid-19, first identified in Luxembourg and since spreading to several countries, is a descendant of the Pirola variant (BA.2.86)

Another COVID-19 variant JN.1 found in Kerala; check symptoms, treatment

The new COVID-19 variant has been found in Kerala district recently. The variants' symptoms are relatively mild and the cases of hospitalisation are less, check details here

India records 56 new Covid cases, total active cases at 1,475: Govt

India saw a single-day rise of 56 new coronavirus infections while the number of active cases was recorded at 1,475, according to Union Health Ministry data updated on Wednesday. The death toll was recorded at 5,31,926, the data updated at 8 am stated. The country's Covid case tally is 4.49 crore (4,49,96,732). The number of people who have recuperated from the disease has increased to 4,44,63,331, and the national recovery rate stands at 98.81 per cent, according to the health ministry's website. The case fatality rate stands at 1.18 per cent. According to the ministry's website, 220.67 crore doses of Covid vaccine have been administered in the country so far.

Study finds benefits of Covid-19 vaccines against severe cases in children

The Murdoch Children's Research Institute led a review of the international literature that was published in BMJ Paediatrics Open that examined the issues surrounding COVID-19 vaccination

72 new Covid cases in India, total active cases at 1,452: Health Ministry

India logged 72 new coronavirus infections in a day while the number of active cases was recorded at 1,452, according to the Union health ministry data updated on Saturday. The death toll stood at 5,31,925, according to the data updated at 8 am. The country's Covid case tally is 4.49 crore (4,49,96,548), it said. The number of people who have recuperated from the disease increased to 4,44,63,171 and the national recovery rate stands at 98.81 per cent, the health ministry said. The case fatality rate stands at 1.18 per cent, it said. According to the ministry's website, 220.67 crore doses of Covid vaccines have been administered in the country so far.

WHO designates Covid-19 variant BA.2.86 as a 'variant under monitoring'

World Health Organization (WHO) designated COVID-19 variant BA.2.86 as a 'variant under monitoring' due to the large number of mutations it carries

WHO classifies EG.5 strain of SARS-CoV-2 virus as 'variant of interest'

The World Health Organization (WHO) has classified the EG.5 strain of the SARS-CoV-2 virus circulating in different parts of the world, including India, as a "variant of interest" but said it did not seem to pose more of a threat to public health than other strains. EG.5 or Eris variant of SARS-CoV-2 was first reported on February 17 this year, and designated as a variant under monitoring (VUM) on July 19. In its latest risk evaluation on Wednesday, the WHO designated EG.5 and its sub-lineages as a variant of interest (VOI). Variants are broadly categorised into three categories: (1) "variants of interest," (2) "variants of concern" and (3) "variants of high consequence. According to the US National Institutes of Health (NIH), VOIs are defined as variants with specific genetic markers that have been associated with changes that may cause enhanced transmissibility or virulence, reduction in neutralisation by antibodies obtained through natural infection or vaccination. EG.5 is a ..

Brain fog, other long Covid symptoms focus of new small treatment studies

The National Institutes of Health is beginning a handful of studies to test possible treatments for long COVID, an anxiously awaited step in U.S. efforts against the mysterious condition that afflicts millions. Monday's announcement from the NIH's USD 1.15 billion RECOVER project comes amid frustration from patients who've struggled for months or even years with sometimes-disabling health problems with no proven treatments and only a smattering of rigorous studies to test potential ones. This is a year or two late and smaller in scope than one would hope but nevertheless it's a step in the right direction, said Dr. Ziyad Al-Aly of Washington University in St. Louis, who isn't involved with NIH's project but whose own research highlighted long COVID's toll. Getting answers is critical, he added, because there's a lot of people out there exploiting patients' vulnerability with unproven therapies. Scientists don't yet know what causes long COVID, the catchall term for about 200 widel

Moderna to keep testing flu shot after initial failures, shares down 8%

The company said, ahead of its annual vaccines conference, that it will continue testing the flu shot for efficacy

TN may introduce mask mandate if Covid cases surge: Health Minister

Tamil Nadu may consider introducing mask mandate in the state if coronavirus cases surge beyond the 500 or 1,000 mark, Health Minister Ma Subramanian said on Tuesday and asserted that it is ideal to wear face masks in crowded places. The State is witnessing a gradual increase in cases, at present, with few cases being reported by the day and there have been five "incidental" coronavirus deaths so far, he said. "The government has not announced any relaxation in the Covid-19 appropriate behaviour and it is safe to wear face masks in crowded places," Subramanian said responding to a call attention motion brought by Leader of Opposition K Palaniswami in the Assembly. Though masks are still compulsory as per the Centre's advisory, people were not taking it seriously, he said. Raising the issue, Palaniswami wondered if people should wear masks as coronavirus cases are increasing by the day and sought to know what steps are being taken by the State government to prevent the spread. "There

Covid-19 cases in India at four-month high: Everything you need to know

Covid-19 review meet: Prime Minister Narendra Modi on Wednesday highlighted that Covid in India is 'far from over' and there is a need to monitor the status of cases across the country regularly

Co-infection with 'superbug' spikes Covid virus replication 15-folds

Researchers have identified a protein found in superbugs that enhances SARS-CoV-2 replication by 10- to 15-fold

H3N2 influenza: Symptoms, spread, prevention, what do experts say?

Common symptoms of seasonal influenza include a sudden fever, a cough (usually dry), a headache, muscle and joint pain, a sore throat, and a runny nose

Low breastfeeding rates in infants born to mothers with Covid-19: Research

An international investigation found that during the height of the pandemic, breastfeeding and skin-to-skin contact rates were low

Germany drops face mask mandate on long-distance transport after 2 yrs

After almost two years, Germany has lifted the mandate to use protective face masks on long-distance trains and buses as the Covid-19 pandemic loosened its grip on the country

China introduces IceBurial tech amid rising number of Covid deaths

Amid the rising number of deaths in China due to COVID-19, it has introduced IceBurial technology which covers first-hand info and unique insights about China and the Chinese Communist Party

Germany to scrap Covid mask rule mandate in long-distance transport

Germany will soon drop a mask mandate on long-distance trains and buses, one of the country's last remaining COVID-19 restrictions, the health minister said on Friday. The mandate will be dropped on February 2, Health Minister Karl Lauterbach announced in Berlin. Other European countries already have scrapped mask mandates in public transport, and Lauterbach faced increasing pressure to follow suit in recent weeks. Masks remain mandatory in doctors' practices, while masks and negative tests are still required to enter hospitals and nursing homes. Rules for local transportation are a matter for Germany's 16 state governments, and an increasing number have dropped or are dropping their mask mandates. Some also have scrapped rules requiring infected people to isolate at home. The long-distance transportation rules were scheduled to end on April 7, though legislation allows for them to be suspended earlier if the situation is better than expected. After one of Germany's top virologis

Himachal Pradesh govt seeks 1 million doses of Covishield vaccine

The government said it is fully geared up to tackle any possible threat due to COVID virus and the basic health infrastructure is being strengthened in all health institutions

Do you still need to wear a mask? Here's what doctors have to say

Doctors say that most people have some form of immunity against the virus already

Zenara Pharma launches generic anti-viral pills for Covid-19 in India

Zenara Pharma, a fully-owned subsidiary of the city-based Biophore India Pharmaceuticals, on Friday announced that it has launched generic Paxlovid (Nirmatrelvir and Ritonavir) tablets in a combi pack as a treatment option for patients with mild to moderate symptoms of Covid-19. A press release from the drug maker said Zenara Pharma has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market this product last month. The product, which will be sold under the brand name 'Paxzen,' is being manufactured at Zenara's US FDA and EU approved state-of-the-art facility in Hyderabad, it said. Pfizer's Paxlovid has been approved by US FDA for COVID treatment. The product will be sold at a Maximum Retail Price of Rs 5,200 per box, equivalent to one full course of treatment per patient, and contains 20 tablets of Nirmatrelvir 150ml and 10 Tablets of Ritonavir 100mg. Jagadeesh Babu Rangisetty, Co-founder and Managing Director at Zenara Pharma, s